IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regulus Therapeutics

CUSIP: 7915K2000 | 1 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Endurance Wealth Management, Inc.675
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Endurance Wealth Management, Inc.
675$00.0%N/AN/AProvidence, RI2023-08-09